Press Release: Alcami Adds Solid-State Characterization Capabilities
Morrisville, North Carolina – September 22, 2022 – Alcami, a U.S.-based pharmaceutical contract...
Morrisville, North Carolina – September 22, 2022 – Alcami, a U.S.-based pharmaceutical contract...
Morrisville, North...
An increasing number of clinical trial registrations, more R&D investment, growing demand for...
Acquisition to add 375,000 ft² of cGMP Biostorage and Pharma Support Services
DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
As opposed to traditional drug production, the production of biological products (biologics)...
From standalone projects through full-service programs, our laboratories provide solutions to your...
Today’s technology has not only changed the way we receive information, but has continually adapted...
Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...
Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated...
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
An FTE agreement is considered a comprehensive analytical service that allows pharmaceutical and...
Durham, NC (USA) – June 13, 2018 – Alcami Corporation, a leading provider of fully-integrated...
As one of the key contributors to current abuse-deterrent studies being performed in the Alcami...